bims-nimamd Biomed News
on Neuroimmunity and neuroinflammation in ageing and metabolic disease
Issue of 2026–11–08
twenty papers selected by
Fawaz Alzaïd, Sorbonne Université



  1. Nature. 2026 Nov;659(8139): S14-S15
      
    Keywords:  Medical research; Neurodegeneration; Neuroscience; Parkinson's disease
    DOI:  https://doi.org/10.1038/d41586-026-03171-3
  2. Nature. 2026 Nov 04.
      
    Keywords:  Medical research; Neuroscience; Parkinson's disease
    DOI:  https://doi.org/10.1038/d41586-026-03173-1
  3. Science. 2026 Nov 05. 394(6824): eaea3046
      Cancer-associated hematopoietic abnormalities contribute to systemic immunosuppression. However, whether tumors can initiate localized extramedullary hematopoiesis to suppress antitumor immunity remains unclear. In this study, we identify a distinct form of hepatic hematopoiesis driven by liver metastasis-associated hematopoietic stem cells (LM-HSCs). Liver metastases establish ectopic periportal hematopoietic niches that recruit bone marrow HSCs through Kupffer cell-dependent C-C motif chemokine receptor 1 (CCR1) signaling. Although LM-HSCs retain self-renewal and multipotency, cAMP response element-binding protein (CREB) activation skews their differentiation toward the myeloid lineage, particularly annexin A1-positive (ANXA1+) immature neutrophils. These neutrophils produce glucocorticoids, which activate glucocorticoid receptor signaling in a paracrine manner and induce immune checkpoint receptor expression and functional anergy in CD8+ T and natural killer cells. Collectively, these findings suggest that liver metastases reprograms hepatic hematopoiesis to promote immunosuppression.
    DOI:  https://doi.org/10.1126/science.aea3046
  4. Cell Metab. 2026 Nov 03. pii: S1550-4131(26)00387-6. [Epub ahead of print]38(11): 2155-2161
      Lipids are spatially and dynamically organized-within organelles, across cell types and organs, and in response to microbial and dietary inputs. Disruption of this organization is a shared mechanism underlying pathological states, including neurodegeneration, cardiovascular disease, and inflammation. In this Voices piece, our authors explore these themes through specific examples.
    DOI:  https://doi.org/10.1016/j.cmet.2026.09.012
  5. Nat Commun. 2026 Oct 07. pii: 11430. [Epub ahead of print]17(1):
      Most studies of CD1d-restricted natural killer T cells (NKT) have focused on type I TRAV10-TRAJ18+ NKT cells that recognise the glycolipid α-GalCer. Our understanding of type II NKT cells, their T cell receptor (TCR) gene usage, and their ligand specificity and diversity remains unclear. Here, using CD1d tetramers carrying diverse endogenous lipids (CD1d-endo), we identified public human TRAV26+ type II NKT TCRs present in all examined individuals, with many expressing a conserved TRAV26-2-TRAJ48 TCRα chain. Cellular, molecular and lipidomic analyses showed that TRAV26+ TCRs bound with similar affinities to CD1d loaded with diverse lipids, suggesting lipid-independent binding. Crystal structures of TRAV26+ TCR-CD1d complexes suggested these TCRs bound solely to the A'-roof of CD1d, distal to the protruding lipid. Collectively, we have uncovered a population of public lipid-independent TRAV26+ type II NKT cells.
    DOI:  https://doi.org/10.1038/s41467-026-78124-5
  6. Nat Commun. 2026 Oct 08. pii: 11460. [Epub ahead of print]17(1):
      Adaptive immune memory generated by bacterial toxin vaccination is well established, but whether bacterial toxins can also induce innate immune memory, or trained immunity (TI), remains unclear. Here, we show that bacterial toxins elicit TI through NLRP3 inflammasome activation both in vitro and in vivo in mice, and that this response is conserved in primary human macrophages. Stimulation with the CNF1 toxin induced an epigenetic remodeling, defining a TI-associated transcriptional signature. A targeted RNAi screen identified Bcl2a1 as a required mediator of TI, and epistasis analyses demonstrated that IL-1 signaling is essential for TI induction in macrophages. In our mouse sepsis model, toxin-induced TI enhanced host resistance and improved survival. These findings establish toxin-driven inflammasome activation as trigger of transient TI and demonstrate that this response enhance resistance during experimental bacterial sepsis.
    DOI:  https://doi.org/10.1038/s41467-026-78499-5
  7. Nat Commun. 2026 Oct 09. pii: 11477. [Epub ahead of print]17(1):
      The fetal immune system develops within a tightly regulated environment that balances immune tolerance with readiness for postnatal antigen exposure. However, limited fetal tissue access constrains understanding of immune ontogeny across compartments. Here we present a multi-tissue single-cell transcriptional atlas of the late-gestation (GD130-135) rhesus macaque fetal immune system, profiling leukocytes from lung, spleen, and umbilical cord blood (UCBMC) spanning myeloid, lymphoid, innate lymphoid, and hematopoietic stem cell lineages. Fetal lung is enriched in myeloid cells and ILC2s and shows a proinflammatory bias. Spleen is dominated by T and B cells, with B cells showing enhanced signatures of V(D)J recombination and isotype switching and CD4 T cells showing increased activation and Treg frequency. UCBMC is predominantly composed of T cells with a regulatory transcriptional landscape. Spectral flow cytometry and functional assays corroborate these tissue-specific differences revealing elevated secretion of inflammatory mediators in fetal lung at rest, while spleen and UCBMC show greater inducible responses following stimulation. Together, these data provide a comprehensive cross-tissue atlas of late-gestation primate fetal immunity, revealing tissue-specific immune specialization, functional capacity, and intercellular communication networks that shape immune readiness prior to birth.
    DOI:  https://doi.org/10.1038/s41467-026-78365-4
  8. Nat Commun. 2026 Oct 07. pii: 11423. [Epub ahead of print]17(1):
      Severe liver injury following major partial hepatectomy (PHx) carries high mortality, yet the mechanisms driving irreversible cell death remain poorly understood. Here we show that aberrant lipid metabolism drives inflammatory cell death in the remaining liver tissue. Integrating data from male mouse models and human tissues, we found that death receptor 5 (DR5) acts as a critical regulator. Mechanistically, DR5 impedes the nuclear entry of the Farnesoid X Receptor (FXR), repressing the production of phosphatidylcholine (PC), an essential structural lipid. This lipid deficiency compromises the integrity of cellular membranes, causing severe stress and lethal pyroptosis. Restoring this pathway via DR5 suppression, FXR activation, or PC supplementation significantly alleviated post-surgical liver injury. Overall, we uncover a non-canonical metabolic function of DR5 that disrupts cellular homeostasis. These findings suggest that modulating this metabolic pathway may offer potential avenues for investigating future management strategies for small-for-size syndrome (SFSS) and post-hepatectomy liver failure (PHLF).
    DOI:  https://doi.org/10.1038/s41467-026-78113-8
  9. Sci Immunol. 2026 Nov 06. 11(125): eaen3917
      Aberrant, cranial bone marrow-derived myelopoiesis drives neuroinflammation in chronic traumatic brain injury.
    DOI:  https://doi.org/10.1126/sciimmunol.aen3917
  10. Nat Commun. 2026 Oct 09. pii: 11483. [Epub ahead of print]17(1):
      Periodontitis is a key driver in the development and progression of liver fibrosis. Nevertheless, how specific periodontal pathogens contribute to liver fibrosis remains elusive. Here, we identify Tannerella forsythia as the crucial mediator in the link between periodontitis and liver fibrosis, which can translocate to the gut and aggravate liver fibrosis. Mechanistically, Tannerella forsythia promotes the infiltration of ICAM-1+ neutrophils and inflammatory response in the liver via disrupting intestinal barrier integrity. ICAM-1+ neutrophils secrete TNF-α, which activates the PI3K/AKT/mTOR pathway in hepatic stellate cells, triggering collagen deposition and fibrogenesis. Conditional knockout of ICAM-1 in neutrophils or global deletion of TNF-α significantly attenuates inflammatory response and liver fibrosis caused by Tannerella forsythia. Taken together, this study identifies an oral-gut-liver axis driven by Tannerella forsythia and provides a prospective therapeutic target for periodontitis-related liver fibrosis.
    DOI:  https://doi.org/10.1038/s41467-026-78008-8
  11. Nat Commun. 2026 11 02. pii: 11125. [Epub ahead of print]17(1):
    HuBMAP Consortium
      The NIH Human BioMolecular Atlas Program (HuBMAP) Data Portal ( https://portal.hubmapconsortium.org/ ) serves as a comprehensive repository for multimodal, multi-scale spatial and single-cell data from healthy human tissues. As of August 2026, the portal hosts 9,316 public datasets from 26 data types spanning 29 organ classes across 501 donors. Portal infrastructure and user interfaces support data search and discovery, visualization, and analysis directly in web browsers. These capabilities include metadata- and data-driven search, collaborative Workspaces with access to high-performance compute, and interactive Vitessce visualizations across non-spatial, 2D, and 3D spatial datasets. Data-type-specific uniform processing pipelines and rigorous quality control processes ensure comparability of results across laboratories, organs, and donors, while externally processed community-contributed datasets provide complementary perspectives. Here we describe portal functionality, infrastructure, and design, and highlight its role as a platform for large-scale spatial single-cell research across diverse data types, organs, and scales.
    DOI:  https://doi.org/10.1038/s41467-026-77835-z
  12. EMBO Rep. 2026 Nov 02.
      Mechanisms linking amyloid peptides to mitochondrial dysfunction and impaired mitophagy in Alzheimer's disease (AD) remain poorly defined. Here, we report that, in healthy aging neurons, mitochondrial ceramide synthase 1 (CerS1) localization accompanies increased mitochondrial C18-ceramide and mitophagy in damaged mitochondria. In neuronal, mouse, and human AD tissues, amyloid precursor protein (APP) or Aβ40, but not Aβ42, shows increased proximity or co-association with TOM20/TOM40 alongside reduced mitochondrial CerS1/C18-ceramide accumulation and mitophagy. Mitochondria-excluded mutant APP does not reproduce these responses in neuronal cells. WT-APP expression is associated with reduced p17/PERMIT-ICT1 proximity, which does not establish direct APP-ICT1 binding or disruption of complex formation. Reduced mitophagy also accompanies lysosomal Aβ42 accumulation and secretion from neurons. Aged CerS1top/top mice, expressing catalytically inactive CerS1, exhibit mitochondrial dysfunction, behavioral deficits, and amyloid-positive plaque accumulation. Treatment with the peptide-targeted nanoparticle Pen-Cera-LCL768, which accumulates in the brain after intranasal administration, increases mitophagy-related readouts, reduces plaque burden, and improves behavioral performance in aged 3xTg and CerS1top/top mice. Mdivi-1 attenuates treatment effects in 3xTg mice, but its lack of specificity limits conclusions about mitophagy dependence.
    DOI:  https://doi.org/10.1038/s44319-026-00984-1
  13. Science. 2026 Nov 05. 394(6824): 633-640
      Pharmacotherapies for obesity and type 2 diabetes are increasingly being evaluated for their effects on cognition and brain health. Evidence from preclinical models, observational cohorts, and clinical trials has intensified interest, but findings remain mixed. A central challenge is to determine whether potential cognitive effects arise from direct actions on neural circuits, indirect consequences of improved cardiometabolic health, or both. This Review examines the evidence across cardiometabolic disease, aging, and Alzheimer's disease, focusing on glucagon-like peptide-1 (GLP-1)-based therapies and combination approaches that engage glucose-dependent insulinotropic polypeptide, glucagon, and amylin pathways. We assess how receptor pharmacology, brain exposure, metabolic context, and disease stage shape cognitive outcomes and discuss how mechanistic clarity could guide therapies aimed at preserving or improving cognition.
    DOI:  https://doi.org/10.1126/science.aek9987
  14. Cell Stem Cell. 2026 Nov 05. pii: S1934-5909(26)00390-5. [Epub ahead of print]
      Programmable epigenome editing offers control of gene expression without altering DNA sequence, but its capacity to program human hematopoietic stem cells (HSCs) and their differentiated progeny remains incompletely characterized. Here, we establish that DNA methylation-based epigenome editors delivered transiently as RNA induce heritable gene silencing in primary human HSCs. Targeting the platelet integrin β3 (ITGB3) produced silencing that persisted through long-term HSC self-renewal and megakaryocytic differentiation, impaired aggregation of in vitro-derived platelets, and was partially reversed through targeted demethylation at this locus. Silencing remained stable in human HSCs 4 months after transplantation into mice. Targeting additional platelet-associated genes demonstrated broad applicability with this approach. Together, these findings establish DNA methylation-based epigenome editing as a platform for durable and reversible programming of human HSCs and demonstrate its application to modulating platelet function.
    Keywords:  DNA methylation; HSC engineering; epigenetics; epigenome editing; hematopoiesis; hematopoietic stem cell; platelet; thrombosis
    DOI:  https://doi.org/10.1016/j.stem.2026.10.009